1. Home
  2. AWRE vs CELU Comparison

AWRE vs CELU Comparison

Compare AWRE & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • CELU
  • Stock Information
  • Founded
  • AWRE 1986
  • CELU 2016
  • Country
  • AWRE United States
  • CELU United States
  • Employees
  • AWRE N/A
  • CELU N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • CELU Health Care
  • Exchange
  • AWRE Nasdaq
  • CELU Nasdaq
  • Market Cap
  • AWRE 56.1M
  • CELU 64.3M
  • IPO Year
  • AWRE 1996
  • CELU N/A
  • Fundamental
  • Price
  • AWRE $2.45
  • CELU $2.05
  • Analyst Decision
  • AWRE
  • CELU Strong Buy
  • Analyst Count
  • AWRE 0
  • CELU 1
  • Target Price
  • AWRE N/A
  • CELU $6.00
  • AVG Volume (30 Days)
  • AWRE 35.2K
  • CELU 165.3K
  • Earning Date
  • AWRE 10-29-2025
  • CELU 08-29-2025
  • Dividend Yield
  • AWRE N/A
  • CELU N/A
  • EPS Growth
  • AWRE N/A
  • CELU N/A
  • EPS
  • AWRE N/A
  • CELU N/A
  • Revenue
  • AWRE $16,146,999.00
  • CELU $44,590,000.00
  • Revenue This Year
  • AWRE N/A
  • CELU N/A
  • Revenue Next Year
  • AWRE N/A
  • CELU $76.00
  • P/E Ratio
  • AWRE N/A
  • CELU N/A
  • Revenue Growth
  • AWRE N/A
  • CELU 4.45
  • 52 Week Low
  • AWRE $1.35
  • CELU $1.00
  • 52 Week High
  • AWRE $2.95
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 47.11
  • CELU 38.22
  • Support Level
  • AWRE $2.35
  • CELU $2.00
  • Resistance Level
  • AWRE $2.84
  • CELU $2.20
  • Average True Range (ATR)
  • AWRE 0.19
  • CELU 0.17
  • MACD
  • AWRE -0.02
  • CELU 0.03
  • Stochastic Oscillator
  • AWRE 26.55
  • CELU 15.33

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: